Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Laure GossecAna Maria OrbaiLaura C CoatesDafna D GladmanPhilip S HelliwellChristopher G PelligraValérie CiaravinoBarbara InkVanessa TaiebJérémy LambertMaarten P T de WitPublished in: RMD open (2024)
The PsAID-12 demonstrated robust psychometric properties in a large sample of patients with active PsA, supporting its use as a fit-for-purpose patient-reported outcome in this population. Furthermore, thresholds for score interpretation were derived.